Candel Therapeutics, Inc.CADLNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-33.37M
↓ 29% below average
Average (5y)
$-25.84M
Historical baseline
Range
High:$-9.04M
Low:$-38.39M
CAGR
+29.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-33.37M | +13.1% |
| 2023 | $-38.39M | -10.6% |
| 2022 | $-34.72M | -35.0% |
| 2021 | $-25.73M | -86.3% |
| 2020 | $-13.81M | -52.8% |
| 2019 | $-9.04M | - |